ArticleInvestigational new drugs2012

Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.

Jason Konner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.